Von Liebig Forum: Alfred Mann
This installment of the “Profiles in Innovation” series features Alfred Mann, the Chairman of the Board and CEO of MannKind Corporation, a diversified biopharmaceutical company that develops novel therapeutics for diabetes, cancer autoimmune and inflammatory diseases. Series: “Von Liebig Forum” [12/2005] [Public Affairs] [Science] [Show ID: 11117]